Ventyx Biosciences’ $176.6 Million Private Placement of Common Stock

Wilson Sonsini Goodrich & Rosati advised Ventyx Biosciences on the deal while Goodwin Procter represented Redmile Group.Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company focused on advancing…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now